KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Prepaid Assets (2016 - 2025)

Jazz Pharmaceuticals has reported Prepaid Assets over the past 16 years, most recently at $324.0 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $324.0 million for Q4 2025, up 82.6% from a year ago — trailing twelve months through Dec 2025 was $324.0 million (up 82.6% YoY), and the annual figure for FY2025 was $324.0 million, up 82.6%.
  • Prepaid Assets for Q4 2025 was $324.0 million at Jazz Pharmaceuticals, up from $146.9 million in the prior quarter.
  • Over the last five years, Prepaid Assets for JAZZ hit a ceiling of $354.2 million in Q3 2024 and a floor of $91.9 million in Q4 2022.
  • Median Prepaid Assets over the past 5 years was $157.1 million (2025), compared with a mean of $191.2 million.
  • Biggest five-year swings in Prepaid Assets: skyrocketed 307.64% in 2021 and later plummeted 58.53% in 2025.
  • Jazz Pharmaceuticals' Prepaid Assets stood at $131.4 million in 2021, then tumbled by 30.06% to $91.9 million in 2022, then skyrocketed by 249.04% to $320.8 million in 2023, then crashed by 44.7% to $177.4 million in 2024, then soared by 82.6% to $324.0 million in 2025.
  • The last three reported values for Prepaid Assets were $324.0 million (Q4 2025), $146.9 million (Q3 2025), and $164.0 million (Q2 2025) per Business Quant data.